الوصف

Sleep quality or inflammation biomarker data from the trial of Montmorency tart cherry powder supplementation in individuals with overweight or obesity, showing limited improvements versus control.

Figure 3

Chart

Source Paper

Commonly Used Dose of Montmorency Tart Cherry Powder Does Not Improve Sleep or Inflammation Outcomes in Individuals with Overweight or …

Nutrients (2024)

PMID: 39683518

DOI: 10.3390/nu16234125

Cite This Figure

![Figure 3: Sleep quality or inflammation biomarker data from the trial of Montmorency tart cherry powder supplementation in individuals with overweight or obesity, showing limited improvements versus control.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11644614/bin/nutrients-16-04125-g003.jpg)

> Source: Robin M Tucker et al. "Commonly Used Dose of Montmorency Tart Cherry Powder Does Not Improve Sleep or I." *Nutrients*, 2024. PMID: [39683518](https://pubmed.ncbi.nlm.nih.gov/39683518/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11644614/bin/nutrients-16-04125-g003.jpg" alt="Sleep quality or inflammation biomarker data from the trial of Montmorency tart cherry powder supplementation in individuals with overweight or obesity, showing limited improvements versus control." />
  <figcaption>Figure 3. Sleep quality or inflammation biomarker data from the trial of Montmorency tart cherry powder supplementation in individuals with overweight or obesity, showing limited improvements versus control.<br>  Source: Robin M Tucker et al. "Commonly Used Dose of Montmorency Tart Cherry Powder Does Not Improve Sleep or I." <em>Nutrients</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39683518/">39683518</a></figcaption>
</figure>

أدلة ذات صلة

الكرز الحامض لـ الأرق

التقييم A · 5 دراسات

الكرز الحامض لـ أرق الحفاظ على النوم

التقييم A · 27 دراسات